Systemic tissue inhibitor of metalloproteinase‐1 gene delivery reduces neointimal hyperplasia in balloon‐injured rat carotid artery

[1]  G. Angelini,et al.  Inhibition of late vein graft neointima formation in human and porcine models by adenovirus-mediated overexpression of tissue inhibitor of metalloproteinase-3. , 2000, Circulation.

[2]  A. Clowes,et al.  Matrix metalloproteinase-9 overexpression enhances vascular smooth muscle cell migration and alters remodeling in the injured rat carotid artery. , 1999, Circulation research.

[3]  H. Lijnen,et al.  Tissue inhibitor of matrix metalloproteinases-1 impairs arterial neointima formation after vascular injury in mice. , 1999, Circulation research.

[4]  H. Lijnen,et al.  Accelerated neointima formation after vascular injury in mice with stromelysin-3 (MMP-11) gene inactivation. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[5]  J. Caillaud,et al.  Adenovirus-mediated overexpression of tissue inhibitor of metalloproteinase-1 reduces atherosclerotic lesions in apolipoprotein E-deficient mice. , 1999, Circulation.

[6]  É. Allaire,et al.  Local overexpression of TIMP-1 prevents aortic aneurysm degeneration and rupture in a rat model. , 1998, The Journal of clinical investigation.

[7]  P. Carmeliet,et al.  Function of the plasminogen/plasmin and matrix metalloproteinase systems after vascular injury in mice with targeted inactivation of fibrinolytic system genes. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[8]  G. Angelini,et al.  Adenovirus-mediated gene transfer of the human TIMP-1 gene inhibits smooth muscle cell migration and neointimal formation in human saphenous vein. , 1998, Human gene therapy.

[9]  J. McEwan,et al.  Expression of matrix metalloproteinases and their inhibitor TIMP-1 in the rat carotid artery after balloon injury. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[10]  P. Carmeliet,et al.  Adenovirus-Mediated Transfer of Tissue-Type Plasminogen Activator Augments Thrombolysis in Tissue-Type Plasminogen Activator–Deficient and Plasminogen Activator Inhibitor-1–Overexpressing Mice , 1997 .

[11]  A. Mahfoudi,et al.  p21CIP1-mediated inhibition of cell proliferation by overexpression of the gax homeodomain gene. , 1997, Genes & development.

[12]  A. Newby,et al.  Increased secretion of gelatinases A and B from the aortas of cholesterol fed rabbits: relationship to lesion severity. , 1997, Atherosclerosis.

[13]  R. Khokha,et al.  Murine tissue inhibitor of metalloproteinases—4 (Timp—4): cDNA isolation and expression in adult mouse tissues 1 , 1997, FEBS letters.

[14]  P. Carmeliet,et al.  Impaired arterial neointima formation in mice with disruption of the plasminogen gene. , 1997, The Journal of clinical investigation.

[15]  M. Davies,et al.  Upregulation of basement membrane-degrading metalloproteinase secretion after balloon injury of pig carotid arteries. , 1996, Circulation research.

[16]  D. Harrison,et al.  Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability. , 1996, The Journal of clinical investigation.

[17]  M. Reidy,et al.  Migration of arterial wall cells. Expression of plasminogen activators and inhibitors in injured rat arteries. , 1996, Circulation research.

[18]  M. Reidy,et al.  Inhibition of matrix metalloproteinase activity inhibits smooth muscle cell migration but not neointimal thickening after arterial injury. , 1996, Circulation research.

[19]  J. McEwan,et al.  Matrix metalloproteinases and cardiovascular disease. , 1995, Circulation research.

[20]  M. Reidy,et al.  Smooth muscle cell migration and matrix metalloproteinase expression after arterial injury in the rat. , 1994, Circulation research.

[21]  M. Reidy,et al.  Matrix metalloproteinases of vascular wall cells are increased in balloon-injured rat carotid artery. , 1994, Journal of vascular surgery.

[22]  H. Birkedal‐Hansen,et al.  Matrix metalloproteinases: a review. , 1993, Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists.

[23]  N. Olson,et al.  Inhibition of smooth muscle cell proliferation in injured rat arteries. Interaction of heparin with basic fibroblast growth factor. , 1992, The Journal of clinical investigation.

[24]  N. Olson,et al.  Intimal smooth muscle cell proliferation after balloon catheter injury. The role of basic fibroblast growth factor. , 1992, The American journal of pathology.

[25]  G. Angelini,et al.  The future of saphenous vein as a coronary artery bypass conduit. , 1989, European heart journal.

[26]  M. Reidy,et al.  Kinetics of cellular proliferation after arterial injury. I. Smooth muscle growth in the absence of endothelium. , 1983, Laboratory investigation; a journal of technical methods and pathology.